Skip to main content
Premium Trial:

Request an Annual Quote

Biotage Reports 68-Percenr Rise in Q1 Sales as Per-Share Loss Climbs 14.2 Percent

NEW YORK, April 27 (GenomeWeb News) - Biotage today said that first-quarter net sales increased 68 percent

 

Net sales for the three months ended increased to 120.6 million SEK ($16.3 million) from 72 million SEK in the year-ago period.

The company said loss per share in the period increased to 0.24 SEK from 0.21 year over year.

 

Additional financials were not disclosed.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.